GSK’s DREAM Of Diabetes Prevention Claim May Come True, But Not For King

02 Oct 2006

• By Daniel Fowler and Mary Jo Laffler

Results of the Diabetes Reduction Assessment with GlaxoSmithKline's Avandia and King's Altace Medication study could support approval of Avandia for prevention of type 2 diabetes, but Altace did not show a significant effect on development of diabetes

GSK’s DREAM Of Diabetes Prevention Claim May Come True, But Not For King

More from Archive

More from Pink Sheet